89 related articles for article (PubMed ID: 22306835)
1. Critique of "Evidence-Based Surgical Hypothesis: The case against BRCA1 and 2 testing".
Nussbaum RL
Surgery; 2012 Apr; 151(4):634-7. PubMed ID: 22306835
[No Abstract] [Full Text] [Related]
2. BRCA testing is important for our patients.
Anderson BO; Javid SH; Calhoun KE; Byrd DR
Surgery; 2012 Apr; 151(4):637-8. PubMed ID: 22306834
[No Abstract] [Full Text] [Related]
3. The case against BRCA 1 and 2 testing.
Lin C; Sasaki T; Strumwasser A; Harken A
Surgery; 2011 Jun; 149(6):731-4. PubMed ID: 21621683
[No Abstract] [Full Text] [Related]
4. [Genetic testing in patients at risk for carcinoma of the breast].
Kiechle M
Dtsch Med Wochenschr; 2006 Oct; 131(43):2420-2. PubMed ID: 17054060
[No Abstract] [Full Text] [Related]
5. Male Breast Cancer: A Study in Small Steps.
Korde LA
Oncologist; 2015 Jun; 20(6):584-5. PubMed ID: 25986243
[TBL] [Abstract][Full Text] [Related]
6. Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing.
de la Cruz J; Andre F; Harrell RK; Bassett RL; Arun B; Mathieu MC; Delaloge S; Gilcrease MZ
Hum Pathol; 2012 Nov; 43(11):1932-9. PubMed ID: 22591913
[TBL] [Abstract][Full Text] [Related]
7. A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes.
Nomizu T; Matsuzaki M; Katagata N; Kobayashi Y; Sakuma T; Monma T; Saito M; Watanabe F; Midorikawa S; Yamaguchi Y
Breast Cancer; 2015 Sep; 22(5):557-61. PubMed ID: 23242612
[TBL] [Abstract][Full Text] [Related]
8. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
[TBL] [Abstract][Full Text] [Related]
9. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center.
Shannon KM; Lubratovich ML; Finkelstein DM; Smith BL; Powell SN; Seiden MV
Cancer; 2002 Jan; 94(2):305-13. PubMed ID: 11900216
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 Testing Among Young Breast Cancer Survivors.
Kehl KL; Giordano SH
JAMA Oncol; 2016 May; 2(5):688-9. PubMed ID: 27244682
[No Abstract] [Full Text] [Related]
11. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
[TBL] [Abstract][Full Text] [Related]
12. BRCA screening.
Med Lett Drugs Ther; 2007 Nov; 49(1274):93-4. PubMed ID: 18007543
[No Abstract] [Full Text] [Related]
13. Genetic testing in women with breast cancer: implications for treatment.
Paterson R; Phillips KA
Expert Rev Anticancer Ther; 2017 Nov; 17(11):991-1002. PubMed ID: 28853307
[TBL] [Abstract][Full Text] [Related]
14. Breast screening overdiagnosis. Protocols are evidence based.
Dobson HM; Thomas JS
BMJ; 2009 Aug; 339():b3262. PubMed ID: 19671610
[No Abstract] [Full Text] [Related]
15. BRCA to the future: towards best testing practice in the era of personalised healthcare.
Capoluongo E
Eur J Hum Genet; 2016 Sep; 24 Suppl 1(Suppl 1):S1-2. PubMed ID: 27514838
[No Abstract] [Full Text] [Related]
16. Issues in the management of occult neoplasia in breast reduction surgery.
White J; Turton P; Dodwell D; Hanby A
Breast J; 2012; 18(2):198-9. PubMed ID: 22284336
[No Abstract] [Full Text] [Related]
17. Infiltrating duct carcinoma within a fibroadenoma.
Iyengar KR; Peh SC; Yip CH; Vijayananthan A
Indian J Cancer; 2009; 46(3):244-6. PubMed ID: 19574682
[No Abstract] [Full Text] [Related]
18. Trends in genetic screening referral in breast cancer patients under the age of forty: 2001-2016.
Crispin M; Udovicich C; Chan S; Wong S; Pitcher M
Breast J; 2018 Nov; 24(6):1109-1111. PubMed ID: 30251447
[No Abstract] [Full Text] [Related]
19. BRCA Testing Dichotomy in Saudi Arabia.
Abusanad A
J Glob Oncol; 2019 Jan; 5():1-2. PubMed ID: 30707664
[No Abstract] [Full Text] [Related]
20. Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.
Nilsson MP; Winter C; Kristoffersson U; Rehn M; Larsson C; Saal LH; Loman N
Fam Cancer; 2017 Apr; 16(2):187-193. PubMed ID: 28120249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
